Savara (SVRA) Capital Expenditures (2010 - 2026)
Savara (SVRA) recorded Capital Expenditures of $222,000 in Q2 2026, compared with $15,000 a year earlier and up 311.1% from the prior quarter.
Powered by 
Analysis
Savara (SVRA) Capital Expenditures (2010 - 2026) Analysis & Trends
On a TTM basis, Savara's Capital Expenditures came in at $280,000 as of Jun 30, 2026; for FY2025, it was $22,000, down 12.0% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of -14.1% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $25,000 in FY2024 (-91.6%), $296,000 in FY2023, $9,000 in FY2022 (-84.2%) and $57,000 in FY2021 (+21.3%).
- The Q2 2026 figure is the highest quarterly Capital Expenditures since Q2 2023.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 975.0% in Q3 2023, against a decline of 93.0% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $54,000 (Q1 2026), $2,000 (Q4 2025) and $2,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Savara | 1.06 Bn | 1.06 Bn | - | 222,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 222,000.00 |
| Mar 31, 2026 | 54,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Dec 31, 2023 | 24,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 225,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Dec 31, 2021 | 40,000.00 |
| Sep 30, 2021 | 11,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Sep 30, 2020 | 18,000.00 |
| Jun 30, 2020 | 20,000.00 |
API Access
Savara Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "SVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();